Headline
The latest stories from AHA Today.
A new report from the National Academies of Sciences, Engineering, and Medicine recommends actions for health care systems, government agencies and others to better integrate patients’ social needs into health care delivery.
Nearly 100 hospital and health system leaders today came together in Washington, D.C., to urge lawmakers to take action on critical issues facing patients and protect access to care.
The Centers for Medicare & Medicaid Services today released premium and cost-sharing information for Medicare Advantage and Part D prescription drug plans for the 2020 calendar year.
The Department of Health and Human Services and Centers for Disease Control and Prevention last night celebrated nearly 350 organizations, including the AHA, during the UN General Assembly in New York for their commitment to combat antimicrobial resistance as part of The AMR Challenge.
The National Health Law Program and Indiana Legal Services yesterday filed a federal lawsuit challenging the administration for approving a Section 1115 waiver for Indiana that requires certain adults to work to maintain Medicaid coverage.
As part of Sepsis Awareness Month, the Centers for Disease Control and Prevention is encouraging patients and health care professionals to share educational materials from its Get Ahead of Sepsis campaign.
The AHA invites hospitals and health systems to participate in the Better Maternal Outcomes Rapid Improvement Network, a free six-month program focused on maternal outcomes and respectful care.
The United States Pharmacopeia today notified stakeholders that it is postponing the official effective dates of several new and revised standards pertaining to pharmaceutical handling until further notice while it reviews appeals to the standards.
The Centers for Medicare & Medicaid Services today issued a final rule delineating a methodology for implementing the Affordable Care Act aggregate reductions to state Medicaid Disproportionate Share Hospital allotments beginning in fiscal year 2020.
U.S. drug prices are nearly four times higher than the combined average price for 11 other similar countries, according to a report released today by the House Ways and Means Committee.